FLUXON 75 MG COM CT BL AL PLAS TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1558405890043 -
GGREM
504620110079207 -
Código de barras
7896714203492
O que a fonte publica
- Detentor do registro
- BRAINFARMA INDÚSTRIA QUÍMICA E FARMACÊUTICA S.A
- Princípios ativos
- CINARIZINA
- Embalagem
- 75 MG COM CT BL AL PLAS TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- C4A2 - ANTAGONISTAS DO CÁLCIO COM AÇÃO CEREBRAL
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "FLUXON 75 MG COM CT BL AL PLAS TRANS X 30",
"holder": "BRAINFARMA INDÚSTRIA QUÍMICA E FARMACÊUTICA S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896714203492"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "504620110079207",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "05.161.069/0001-10",
"priceRegime": "Regulado",
"productName": "FLUXON",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "75 MG COM CT BL AL PLAS TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "12.89",
"icms-12": "14.65",
"icms-17": "15.53",
"icms-18": "15.72",
"icms-19": "15.91",
"icms-20": "16.11",
"icms-21": "16.32",
"icms-22": "16.53",
"icms-23": "16.74",
"icms-17.5": "15.62",
"icms-19.5": "16.01",
"icms-20.5": "16.21",
"icms-22.5": "16.63",
"icms-12-alc": "14.47",
"icms-17-alc": "15.34",
"icms-18-alc": "15.53",
"icms-19-alc": "15.72",
"icms-20-alc": "15.92",
"icms-21-alc": "16.12",
"icms-22-alc": "16.33",
"icms-23-alc": "16.54",
"withoutTaxes": "12.74",
"icms-17.5-alc": "15.44",
"icms-19.5-alc": "15.82",
"icms-20.5-alc": "16.02",
"icms-22.5-alc": "16.43"
},
"pisCofinsList": "Positiva",
"substanceText": "CINARIZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "17.77",
"icms-12": "20.19",
"icms-17": "21.41",
"icms-18": "21.67",
"icms-19": "21.93",
"icms-20": "22.21",
"icms-21": "22.50",
"icms-22": "22.78",
"icms-23": "23.07",
"icms-17.5": "21.53",
"icms-19.5": "22.07",
"icms-20.5": "22.34",
"icms-22.5": "22.92",
"icms-12-alc": "20.00",
"icms-17-alc": "21.21",
"icms-18-alc": "21.47",
"icms-19-alc": "21.73",
"icms-20-alc": "22.01",
"icms-21-alc": "22.28",
"icms-22-alc": "22.58",
"icms-23-alc": "22.87",
"withoutTaxes": "17.61",
"icms-17.5-alc": "21.34",
"icms-19.5-alc": "21.87",
"icms-20.5-alc": "22.15",
"icms-22.5-alc": "22.71"
},
"invalidBarcodes": [],
"activeSubstances": [
"CINARIZINA"
],
"therapeuticClass": "C4A2 - ANTAGONISTAS DO CÁLCIO COM AÇÃO CEREBRAL",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1558405890043",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C4A2",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:504620110079207"